Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 440 record(s)

Req # A-2023-000449

The number of adverse reaction reports received by Health Canada for a neuroleptic drug from April 1, 2020 to March 31, 2023.

Organization: Health Canada

1 page(s)
July 2023

Req # A-2023-000490

Recently published vaccine injury compensation stats. The list of all vaccines that were submitted for consideration of causal injury. Include even if the findings were not causal and the claim was turned down. The ages of the claimants, and what the alleged injury/death was.

Organization: Health Canada

0 page(s)
July 2023

Req # A-2023-000509

Ministerial briefing notes regarding martial arts, mixed martial arts, boxing or combative sports. Records from November 1, 1993 to July 1, 2023.

Organization: Health Canada

0 page(s)
July 2023

Req # A-2023-000510

Ministerial briefing notes regarding martial arts, mixed martial arts, boxing or combative sports. Records from November 1, 1993 to July 1, 2023.

Organization: Health Canada

0 page(s)
July 2023

Req # A-2023-000520

For each quarter between July 1st, 2022 and June 30th, 2023. Information on the following drugs; Hemophilia A: BeneFIX, Rixubis, Alprolix, Rebinyn, and Immunine. Hemophilia B: Kovaltry, Nuwiq, Zonovate, Xyntha, Esperoct, Jivi, Eloctate, Adynovate, Hemlibra, Alphanate, Humate-P, and Wilate. Bypassing Agents: NiaStase, Obizur, Sevenfact, and FEIBA. Hereditary Angioedema: Orladeyo, Takhzyro, Firazyr, Cinryze, Berinert, Haegarda, Tranexamic Acid, and Danazol. The total volume purchased of each drug by the Canadian Blood Services.

Organization: Health Canada

0 page(s)
July 2023

Req # A-2020-000843

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109831-451.

Organization: Health Canada

33 page(s)
July 2023

Req # A-2020-000930

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111487-77.

Organization: Health Canada

1 page(s)
July 2023

Req # A-2020-001753

Adverse Drug Reaction (ADR). Report number: E2B_03462673.

Organization: Health Canada

13 page(s)
July 2023

Req # A-2021-001139

Adverse Drug Reaction (ADR) for FLUDARABINE PHOSPHATE. Report number: E2B_03522367.

Organization: Health Canada

25 page(s)
July 2023

Req # A-2021-002058

Adverse Drug Reactions (ADRs). Report numbers: E2B_03833163, E2B_03711903, E2B_04785284, E2B_04793915.

Organization: Health Canada

57 page(s)
July 2023
Date modified: